DELFI and Immunocore enter research collaboration with assay for cancer monitoring in multiple solid tumor types
DELFI Diagnostics, Inc., a developer of accessible blood-based tests that deliver a new way to enhance cancer detection, announced availability of the company's fragmentome-based research use only (RUO) cancer monitoring assay. The DELFI-Tumor Fraction (DELFI-TF)...
Group announces inaugural meeting and charter to promote the use of GenAI in life sciences research and development
ArisGlobal , a leading innovative life sciences technology company and inventor of LifeSphere®, announced the formal constitution of the new GenAI Council, which will meet for the first time this month.
The Global...
Through a Combination of Advanced Imaging and Novel Artificial Intelligence, Latest Diagnostic System for Cervical Cancer Screening Can Help More Accurately Detect Disease, Improve Workflow and Enhance Patient Care
Hologic, Inc. announced that its new Genius™ Digital Diagnostics System with the Genius™ Cervical AI algorithm has received clearance from the...
Newly created position will scale the growth of Beacon's breakthrough technology to understand brain activity, and help accelerate the development of new treatment approaches
Beacon Biosignals, a leading computational neurodiagnostics and EEG analytics company, has appointed David Matthews, PhD, as Chief Business Officer to oversee commercial and strategic activities.
Beacon Biosignals partners with...
The new no-code protocol library and AI-powered protocol generation tools will empower scientists with automated, easy-to-use workflows for genomics, proteomics, cell biology, and synthetic biology
Opentrons Labworks, Inc., a leader in lab automation and makers of accessible lab robotics, announced the launch of its new protocol library, offering plug-and-play protocols...
Vivodyne, a biotech that accelerates the successful discovery, design, and development of human therapeutics, announced the appointment of Elliot Menschik, M.D., Ph.D., to the company’s Board of Directors and to the executive role of Chief Technology Officer (CTO). Dr. Menschik brings more than 25 years of industry experience as...
DIA, a global organization of life science professionals, and the Tufts Center for the Study of Drug Development (Tufts CSDD) have come together to conduct a study that furthers the understanding of how artificial intelligence (AI) supports the continuum of drug development.
The study is supported by 16 leading biopharmaceutical companies...
C3 AI, the Enterprise AI application software company, announced that Genentech, the medical biotechnology company, has selected C3 AI Reliability as the continued provider for AI-based predictive maintenance software on the company’s biologics manufacturing equipment.
The biotechnology company began using the AI application in 2021 to ensure centrifuges in the facility...
AION Labs, the first-of-its-kind venture studio spearheading the adoption of AI technologies and computational science to solve therapeutic challenges, announced the formation of TenAces Biosciences. TenAces is a startup developing a novel approach to discover new molecular glue therapies, leveraging machine learning to enhance development of treatments for a...
BullFrog AI Holdings, Inc., a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, announced the appointment of two distinguished scientific advisors to its advisory board: Gwenn S. Smith, PhD, and Jeremiah Wala, MD, PhD.
“We are thrilled to...
